lncRNA STEAP3-AS1 Modulates Cell Cycle Progression via Affecting CDKN1C Expression through STEAP3 in Colon Cancer

Heya Na, Xiaomeng Li, Xinsheng Zhang, Yue Xu, Yuzhu Sun, Jingyi Cui, Zihao Chen, Xiaomeng Shi, Shuangyi Ren, Yunfei Zuo

Molecular Therapy — Nucleic Acids · 2020 · 42 citations · 33 references

DOIFull text

Open access

Concepts

Abstract

phase. In tumorigenicity assays, STEAP3-AS1 knockdown could strongly inhibit tumor growth. Mechanistic investigations demonstrated that STEAP3-AS1 downregulation could increase the expression of cyclin-dependent kinase inhibitor 1C (CDKN1C) by STEAP3 upregulation. Overall, we identify the underlying role of MT1M-related lncRNA STEAP3-AS1 in colon cancer progression, which provides a novel strategy for colon cancer therapy.

References

33